Organ procurement organization (OPO) performance is generally evaluated by the number of organ procurement procedures divided by the number of eligible deaths (donation after brain death [DBD] donors aged <70 years), whereas the number of noneligible deaths (including donation after cardiac death donors and DBD donors aged >70 years) is not tracked. The present study aimed to investigate the variability in the proportion of noneligible liver donors by the 58 donor service areas (DSAs). Patients undergoing liver transplant (LT) between 2011 and 2015 were obtained from the United Network for Organ Sharing Standard Transplant Analysis and Research file. LTs from noneligible and eligible donors were compared. The proportion of noneligible liver donors by DSA varied significantly, ranging from 0% to 19.6% of total liver grafts used. In transplant programs, the proportion of noneligible liver donors used ranged from 0% to 35.3%. On linear regression there was no correlation between match Model for End-Stage Liver Disease score for programs in a given DSA and proportion of noneligible donors used from the corresponding DSA (p = 0.14). Noneligible donors remain an underutilized resource in many OPOs. Policy changes to begin tracking noneligible donors and learning from OPOs that have high noneligible donor usage are potential strategies to increase awareness and pursuit of these organs.
Introduction
An ongoing disparity exists between the supply of liver grafts and the demand of sick patients on liver transplant (LT) waiting lists. A White House "organ summit" recently took place in an effort to combat the shortage of life-saving donor organs through both innovative science and effective public policy (1) . With these objectives in mind, the transplant community continues to pursue strategies to maximize the utilization of the precious resource of donor livers. The primary units of allocation for livers in the Unites States are the 58 donor service areas (DSAs), each served by its respective organ procurement organization (OPO) (2) . OPO performance is generally evaluated by the number of organ procurement procedures divided by the number of eligible deaths (donation after brain death [DBD] donors aged <70 years), whereas the number of noneligible deaths (including donation after cardiac death [DCD] donors and DBD donors aged >70 years) is not explicitly tracked. Consequently, OPO efficiency is determined by its efficiency in converting eligible deaths into actual donors, with potential livers from noneligible donors going largely unrecognized.
As we continue to pursue novel strategies to increase liver graft availability, certain groups have increasingly pursued livers from these noneligible donors, with favorable results. A recent study investigating the national outcomes with the usage of DCD donors for LTs demonstrated significant improvements over time, suggesting that initial reservations about DCD liver graft usage may no longer be warranted (3) . Indeed, results from large single-center studies have demonstrated similar outcomes for DCD and DBD LTs (4, 5) . As the population in the United States continues to age, there will also be an increase in the number of potential donors aged >70 years. Recent studies have suggested that the outcomes of LT with donors aged ≥70 and <70 years are comparable with appropriate donor management (6, 7) .
In an attempt to increase the number of available liver grafts, greater emphasis on and recognition of the pursuit of noneligible donors may represent an important step forward. The present study aimed to investigate the variability in the proportion of noneligible liver donors by the 58 DSAs and the outcomes with the use of noneligible compared with eligible donors for LT.
Materials and Methods
After approval from the Mayo Clinic institutional review board, data were obtained and extracted from the United Network of Organ Sharing (UNOS) Standard Analysis and Research file. The study population included all LTs performed in the United States from January 1, 2011, to December 31, 2015.
Eligible donors, as defined by the Organ Procurement and Transplantation Network (OPTN), included patients aged ≤70 years who were declared brain dead (excluding those with specific active infections). Noneligible donors were defined as those patients aged >70 years who were declared brain dead and all DCD donors. Because the majority of noneligible donors used for LT were those aged >70 years and DCD donors, other categories of noneligible donors with specific active infections or malignancy were not investigated in the current analysis. The percentage of noneligible liver donors was defined as the number of noneligible liver donors divided by the total number of liver donors used for LT. Recipients by transplant centers and were completed by data from the U.S. Social Security Administration and OPTN.
All statistical analyses were performed using STATA 12 (StataCorp, College Station, TX). Differences between groups were analyzed using the unpaired t-test for continuous variables and by the v 2 test or continuity correction method for categorical variables. Wilcoxon rank-sum was used for variables that did not display a normal distribution. Survival curves for patient or graft survival were generated using the Kaplan-Meier method and compared using the log-rank test. All statistical tests were two-sided, and differences were considered significant if p < 0.05.
Results
In the 5-year period between January 1, 2011, and December 31, 2015, a total of 30 126 LTs were performed nationally. This included 27 498 LTs from eligible donors and 2628 LTs from noneligible donors. Of the noneligible donors, 1591 were DCD donors and 1037 were donors aged >70 years.
The proportion of noneligible liver donors by DSA ranged from 0% to 19.6% of the total number of liver donors used for transplant. DSAs were ranked by percentile: the 90th percentile had DSAs with >16.7% noneligible donors, the 75th percentile had 12.7-16.6% noneligible donors, the 50th percentile had 8.6-12.6%, the 25th percentile had 5.4-8.5%, and <25th percentile had <5.3% ( Figure 1 ).
Median match MELD score was calculated for all transplant programs. On linear regression there was no correlation between match MELD score for transplant programs and the proportion of noneligible donors used from the corresponding DSA (p = 0.14). Median match MELD score by programs within a given DSA can be seen in Figure 2 . There was no correlation between biological MELD score for transplant programs and the proportion of noneligible donors used from the corresponding DSA (p = 0.36). There was also no correlation between a DSA's eligible donor conversion rate and the proportion of noneligible donors (p = 0.43) (Figure 3 ). When the proportion of noneligible liver donors used was investigated by transplant program, the range was 0% to 35.3% (Figure 4 ). The transplant programs that used the highest proportion of noneligible liver donors (90th percentile) were all located in DSAs with a high proportion of noneligible liver donors (≥75th percentile). DSAs with a high proportion of noneligible donors that did not contain a transplant program that used a high proportion of noneligible donors were located in a DSA adjacent to one of the programs in the 90th percentile of noneligible donor usage.
Recipients of noneligible donor organs differed from recipients of organs from eligible donors in several ways ( A subanalysis was performed looking at graft survival between eligible and noneligible donors at centers that had the highest usage of noneligible donors by volume (top 20%) compared with all other centers. No difference between eligible and noneligible donors was seen at the highest volume centers (p = 0.10), whereas a significant difference was seen between eligible and noneligible donors at the remaining centers (bottom 80%; p = 0.005) (Figure 7 ).
Discussion
The current study demonstrates that the proportion of noneligible liver donors varies significantly by DSA. There was no correlation between the median match MELD score at transplant between programs in a given DSA and the proportion of noneligible donors that came from that DSA. In addition, there was no difference in patient survival for recipients of organs from noneligible and eligible liver donors.
There is a necessity to increase the liver donor pool to address the disparity between the supply of liver grafts and the demand of sick patients on the waiting list nationally. This disparity has resulted in some centers aggressively pursuing all organ offers, including those from noneligible donors. The present study merely highlights the extreme variance in the pursuit of noneligible donors nationally and does not provide an explanation of why such wide variation exists. Although some authors have suggested that high median MELD scores may push programs to pursue higher risk liver grafts (8), we did not find any such correlation between median MELD score and the proportion of noneligible donors used in the present study. The reasons for the extreme variance in usage of noneligible donors is likely multifactorial.
Previous studies have demonstrated an increased OPO cost associated with the pursuit of expanded criteria donors (9) . Indeed, many OPOs do not routinely pursue noneligible donors because of perceived barriers of cost effectiveness. This, coupled with the fact that, in general, noneligible donors result in fewer organs per donor, likely affects OPO decision making. Pursuit of single-organ donors drives up the liver standard acquisition charge, as all of the costs are allocated to the single organ rather than spread across multiple organ systems.
This study alludes to the potentially synergistic relationship between OPOs and local transplant centers that drives pursuit of noneligible donors. All DSAs with the highest proportions of noneligible donors (>75th percentile) had a transplant center with high usage of noneligible donors either within the DSA or in a directly adjacent DSA. This likely highlights the fact that OPOs pursue noneligible donors when they are easy to place in local centers and when they have local centers that are consistently interested in pursuing those organs. When local centers do not routinely pursue these organs, OPOs may falsely assume that other regional or national transplant programs also would not be interested in these organs or that these livers are "not usable." These noneligible donors may never be worked up or may not be offered to other regional or national centers. Previous authors have shown that significant center variability in accepting organ offers exists (10) . In the present study, transplant center variance in noneligible donor utilization ranged from 0% to 35.6% of total LTs performed. It may also be possible that transplant centers that routinely use noneligible donors may be less likely to travel long distances for these organs because of significant concerns with prolonged CIT in a marginal liver graft. It should be noted, however, that all 11 UNOS regions contained at least a small number of centers that pursue these liver grafts.
Some reluctance at certain transplant centers to use noneligible donors may be related to the perceived inferiority of these organs compared with organs from eligible donors. As more updated reports continue to show improving outcomes with both DCD donors (3) and elderly donors (7), when used in appropriate recipients, it is possible that we may see this reluctance wane. As the present study suggests, there are likely differences among the chosen recipients when using organs from noneligible compared with eligible donors. Patients receiving these noneligible livers generally had lower biological and match MELD scores and more frequently had HCC. Recent data specifically looking at HCC recurrence demonstrated no difference between recipients of DCD and DBD organs (11) . Indeed, patients with HCC may represent ideal DCD LT candidates because of their relatively low biological MELD scores. This may be particularly important in regions of the country where high MELD scores are required to receive a liver offer, especially where MELD exception scores for HCC are now capped at 34. Using organs from noneligible donors in patients with lower biological MELD scores is likely important to achieve more favorable results because these patients can better "weather the storm" of potential delayed graft function from a more marginal liver graft (12) . Our analysis also demonstrates that graft survival was similar for noneligible and eligible donors at high-volume centers, whereas a statistical difference between these groups was seen at other centers. This may suggest that center experience results in better outcomes with marginal donors. In this case, broader utilization of these donors may be best accomplished by better systems to expedite organ placement at centers that can use these organs effectively.
In an attempt to increase the pursuit of noneligible donors, there may be a need to change the national tracking of OPO performance. Because OPOs are largely evaluated on the conversion rate of eligible donors, there is little incentive to pursue noneligible donors. If policy were changed so that OPOs were tracked on both eligible and noneligible donors, there might be a greater impetus to pursue these organs, even if local centers were not directly interested. This strategy may be better achieved not by punishing OPOs with lower noneligible donor rates but rather by rewarding those OPOs that achieve higher rates.
Liver simulated allocation models used to investigate disparity across DSAs have been based on eligible donor deaths, with no modeling component to account for noneligible donors (13) . Although redrawing of national organ-sharing boundaries may decrease disparity in match MELD scores, we must continue to pursue all novel strategies to increase the total donor pool across the country. In many OPOs noneligible donors remain a largely underutilized resource. OPO performance should continue to be evaluated based on the conversion rate of eligible donors; however, a metric tracking performance with regard to noneligible donors should be added. In a hypothetical scenario in which all OPOs currently below the national average for noneligible donor utilization were to increase their noneligible donor rate to the national average (10.5%), an 759 additional donors would result over a 5-year period.
Limitations of the present study are related largely to the fact that these data simply demonstrate the variance in the proportion of noneligible donors nationally and do not provide data on why this variance exists. The goal of this study was not to criticize OPOs with lower proportions of noneligible donors but rather to bring this issue to the forefront and perhaps provide an impetus to change policy so that these metrics are tracked to evaluate OPO performance. In addition, because noneligible donors were compared as a proportion of total donors, OPOs with very high conversion rates for eligible donors may be unfairly disadvantaged because of an increase in their denominator. Because potential noneligible donors are not tracked, it is not possible to know how many potential noneligible donors were in each DSA; therefore, data exist only on how many noneligible donors from each DSA were used. It should also be noted that nationally, a difference exists in demographics by race, religion, and patient age, all of which may contribute to some of the differences in noneligible donor use seen across DSAs. In conclusion, this study highlights the widespread disparity in the usage of noneligible donors across DSAs. As a transplant community with a continued focus on combating the shortage of life-saving donor organs through both innovative science and effective public policy, we must pursue all possible sources to increase the availability of donor organs. Noneligible donors remain an underutilized resource in many OPOs. Policy changes to begin tracking noneligible donors and learning lessons from OPOs that have high noneligible donor usage are potential strategies to increase awareness and pursuit of these organs.
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